Loading
Loading…
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
8 Aug 2025, 11:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Ivermectin Tablet (Q2)
Diethylcarbamazine (DEC) Tablet (Q2) 300 mg Tablet (Q1)
Hydroxyurea Capsule (Q2) Ondansetron Tablet (Q2)
Letrozole Tablet (Q2) (3 (3 ) ) Minimum Average Annual Turnover of the bidder (For 3 Years) 1 Lakh (s) ( ( 3 3 ))
8151034
GEM/2025/B/6507136
Two Packet Bid
Ivermectin Tablet
JALANDHAR CITY
Item wise evaluation
PRODUCT
7 documents required · 7 mandatory
₹1 L
80%
Exempted
8 Aug 2025
16 Aug 2025
8 Aug 2025
Ivermectin Tablet (Q2)
Diethylcarbamazine (DEC) Tablet (Q2) 300 mg Tablet (Q1)
Hydroxyurea Capsule (Q2) Ondansetron Tablet (Q2)
Letrozole Tablet (Q2) (3 (3 ) ) Minimum Average Annual Turnover of the bidder (For 3 Years) 1 Lakh (s) ( ( 3 3 ))
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8151034.pdf
GEM_BID
isoniazid-300mg-pc-11-updated-feb-2021_2022-04-13-12-48-05_eeb1caa0dee44e836051b46bc7819ed1.pdf
OTHER
ATC_46e7f17d-1c82-44eb-aa4d1753764388518_LP_MHJRC.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .